T2 Biosystems Inc (TTOO)
0.4302
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 09:52
T2 Biosystems Revenue (Quarterly): 1.985M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.985M |
| June 30, 2024 | 1.952M |
| March 31, 2024 | 2.061M |
| December 31, 2023 | 1.679M |
| September 30, 2023 | 1.472M |
| June 30, 2023 | 1.964M |
| March 31, 2023 | 2.078M |
| December 31, 2022 | 5.483M |
| September 30, 2022 | 3.677M |
| June 30, 2022 | 5.911M |
| March 31, 2022 | 7.234M |
| December 31, 2021 | 6.98M |
| September 30, 2021 | 7.428M |
| June 30, 2021 | 6.694M |
| March 31, 2021 | 6.956M |
| December 31, 2020 | 7.788M |
| September 30, 2020 | 5.245M |
| June 30, 2020 | 2.552M |
| March 31, 2020 | 2.545M |
| December 31, 2019 | 3.069M |
| September 30, 2019 | 1.677M |
| June 30, 2019 | 1.804M |
| March 31, 2019 | 1.785M |
| Date | Value |
|---|---|
| December 31, 2018 | 1.792M |
| September 30, 2018 | 2.466M |
| June 30, 2018 | 3.931M |
| March 31, 2018 | 2.311M |
| December 31, 2017 | 1.661M |
| September 30, 2017 | 1.108M |
| June 30, 2017 | 0.956M |
| March 31, 2017 | 0.941M |
| December 31, 2016 | 0.909M |
| September 30, 2016 | 1.084M |
| June 30, 2016 | 0.99M |
| March 31, 2016 | 1.096M |
| December 31, 2015 | 1.011M |
| September 30, 2015 | 1.049M |
| June 30, 2015 | 0.564M |
| March 31, 2015 | 0.188M |
| December 31, 2014 | 0.119M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 0.055M |
| September 30, 2013 | 0.091M |
| June 30, 2013 | 0.12M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.472M
Minimum
Sep 2023
7.788M
Maximum
Dec 2020
4.238M
Average
3.373M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Cardinal Health Inc | 52.28B |
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 14.67M |
| Xtant Medical Holdings Inc | 27.94M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -10.12M |
| Total Expenses (Quarterly) | 12.15M |
| EPS Diluted (Quarterly) | -0.57 |
| Enterprise Value | 18.80M |
| Gross Profit Margin (Quarterly) | -106.6% |
| Profit Margin (Quarterly) | -509.7% |
| Earnings Yield | -1.49K% |
| Normalized Earnings Yield | -1512.57 |